We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,154 results
  1. Transformation of Chronic Lymphocytic Leukemia into Acute Mixed Phenotype Leukemia Myeloid/T Neoplasm: a Case Report

    Chronic lymphocytic leukemia (CLL) is defined by the presence of lymphocyte in the blood, bone marrow, lymph nodes, and spleen, with a median...

    Pegah Babaheidarian, Alireza Sadeghipour, ... Fatemeh Tajik in SN Comprehensive Clinical Medicine
    Article 11 September 2023
  2. t(1;4) translocation in a child with acute lymphoblastic leukemia: a case report

    Background

    Acute lymphoblastic leukemia is the most common childhood cancer, with an 80% frequency in children between 1 and 10 years old. The outcome...

    Chaimae El Mahdaoui, Nezha Hda, ... Siham Cherkaoui in Journal of Medical Case Reports
    Article Open access 12 December 2023
  3. Th1 cytokines in pediatric acute lymphoblastic leukemia

    Immune milieus play an important role in various types of cancer. The present study focuses on the effect of Th1 cytokines on pediatric acute...

    Sarah Schober, Jennifer M. Rottenberger, ... Manon Queudeville in Cancer Immunology, Immunotherapy
    Article Open access 23 August 2023
  4. Xeroderma pigmentosum and acute myeloid leukemia: a case report 

    Background

    Xeroderma pigmentosum is a rare inherited disease characterized by extreme hypersensitivity to ultraviolet rays and predisposing to...

    H. Bencharef, M. Lamchahab, ... A. Quessar in Journal of Medical Case Reports
    Article Open access 26 August 2021
  5. Primary Mold-Active Antifungal Prophylaxis Decreases the Need for Chest Computed Tomography Scans in Patients with Acute Lymphoblastic Leukemia

    Current guidelines recommend computed tomography (cCT) scans of the chest in children with leukemia following 96 h of the onset of idiopathic...

    Nihal Karadaş, Hamiyet Hekimci Özdemir, ... Deniz Yilmaz Karapinar in Indian Journal of Hematology and Blood Transfusion
    Article 20 September 2023
  6. Daratumumab—a novel treatment strategy in relapsed/refractory acute leukemia

    Pronamee Borah, Nitin Dayal, ... Rahul Naithani in Annals of Hematology
    Article 09 August 2023
  7. Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms

    CFI-400945 is a selective oral polo-like kinase 4 (PLK4) inhibitor that regulates centriole duplication. PLK4 is aberrantly expressed in patients...

    Tracy Murphy, Jacqueline M. Mason, ... Karen W. L. Yee in Leukemia
    Article 19 December 2023
  8. Cardiac electrical abnormalities in childhood acute lymphoblastic leukemia survivors: a systematic review

    Purpose

    The aim was to provide evidence about the prevalence, incidence, and risk factors of cardiac electrical abnormalities in childhood acute...

    Émilie Bertrand, Maxime Caru, ... Daniel Curnier in Cardio-Oncology
    Article Open access 11 November 2023
  9. Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations

    Germline mutations in RUNX1 result in rare autosomal-dominant familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML). As...

    Kazunori Toratani, Mizuki Watanabe, ... Akifumi Takaori-Kondo in International Journal of Hematology
    Article 10 March 2023
  10. Prevalence of hopelessness and suicidal ideation and their associated factors among pediatric patients with leukemia

    Background

    With the increasing survival rate of pediatric patients with leukemia, improving their quality of life (QoL) is the new challenge....

    Omid Reza Zekavat, Negar Safari, ... Haleh Bozorgi in Middle East Current Psychiatry
    Article Open access 29 September 2023
  11. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia

    Introduction

    Acute lymphoblastic leukemia (ALL) is the most common cancer among children. Measurable residual disease (MRD, previously named minimal...

    Eduardo Ramos Elbal, Jose Luis Fuster, ... Alfredo Minguela in Clinical and Translational Oncology
    Article 27 June 2023
  12. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology

    The latest findings in iron metabolism and the newly uncovered process of ferroptosis have paved the way for new potential strategies in...

    Muhammad Hossein Ashoub, Razieh Razavi, ... Mahnaz Amiri in European Journal of Medical Research
    Article Open access 09 April 2024
  13. Reduce proliferation of human bone marrow cells from acute myeloblastic leukemia with minimally differentiation by blocking lncRNA PVT1

    Purpose

    Acute myeloblastic leukemia with minimally differentiation (AML-M0) is a subtype of acute leukemia with poor prognosis. The recent studies...

    A. Ghadiri, M. Sharifi, ... P. Bagheri in Clinical and Translational Oncology
    Article 14 May 2020
  14. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies

    The members of the Poly(ADP‐ribose) polymerase (PARP) superfamily are involved in several biological processes and, in particular, in the DNA damage...

    Antonella Padella, Andrea Ghelli Luserna Di Rorà, ... Giorgia Simonetti in Journal of Hematology & Oncology
    Article Open access 22 January 2022
  15. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia

    Purpose

    Although outcomes of children with acute myeloid leukemia (AML) have improved over the last decades, around one-third of patients relapse....

    Eduardo Ramos Elbal, José Luis Fuster, ... Alfredo Minguela in Clinical and Translational Oncology
    Article 04 January 2023
  16. Monocytosis and Multiple Myeloma: treatment-related acute leukaemia?

    Background

    Therapy-related acute monocytic leukemias in patients with plasma cell dyscrasias are infrequent.

    Case presentation

    We here present a case...

    Cristina Veronica Trinidad Esparza, Maria J. Lizardo-Thiebaud, ... Daniel Montante Montes de Oca in Surgical and Experimental Pathology
    Article Open access 20 April 2022
  17. Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemia

    Eligibility criteria for clinical trials are intended to select suitable study subjects but can limit trial participation and generalization of...

    Corentin Orvain, Megan Othus, ... Roland B. Walter in Leukemia
    Article 03 June 2022
  18. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16

    All- trans retinoic acid (ATRA)-based therapy for acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML), is the most...

    Vilma Dembitz, Hrvoje Lalic, ... Dora Visnjic in International Journal of Hematology
    Article 21 September 2021
  19. Mutations in the histone methyltransferase Ezh2 drive context-dependent leukemia in Xenopus tropicalis

    CRISPR-mediated simultaneous targeting of candidate tumor suppressor genes in Xenopus tropicalis allows fast functional assessment of co-driver genes...

    Dieter Tulkens, Marthe Boelens, ... Kris Vleminckx in Leukemia
    Article 04 October 2023
Did you find what you were looking for? Share feedback.